Home›Companies›Biotech & Pharma›Promedix

Promedix, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 17, 2024·Suggest an edit

About Promedix

Promedix is a private company based in Portland, Oregon. It has reported $922,778 raised in four offerings on Form D since April 2021. Its chief executive is Scott Filer.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 2, 2024Dec 17, 2024$200,000fully sold1$200KOptions, Securities on exerciseRule 506(b)Form D ↗
Oct 17, 2022Oct 31, 2022amended Sep 11, 2023$310,000fully sold4$77,500Equity, Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Oct 31, 2022Oct 31, 2022amended Sep 11, 2023$162,778fully sold3$54,259Debt, Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Apr 9, 2021Apr 23, 2021$250,000fully sold1$250KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Total, four offerings$922,778

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Promedix's Form D filed Dec 17, 2024.

MH
Matthew Hansen
Executive officer and director
SB
Steven Baker
Executive officer
SF
Scott Filer
Chief Executive Officer and director
DS
David Sheridan
Executive officer and director
RJ
Robert Jenks
Executive officer

Earlier filings also listed Andrew Kibler (executive officer and director, last listed Apr 2021).

Sources

  1. SECPromedix, Inc. Form D, filed Oct 31, 2022
  2. SECPromedix, Inc. Form D, filed Oct 31, 2022
  3. SECPromedix, Inc. filing history